Short telomeres in patients with vascular dementia: An indicator of low antioxidative capacity and a possible risk factor?

Laboratory Investigation

Volumn 80, Issue 11, 2000, Pages 1739-1747

  Von Zglinicki, Thomas ^a   Serra, Violeta ^a   Lorenz, Mario ^a   Saretzki, Gabriele ^a   Lenzen Großimlighaus, Romana ^a   Geßner, Reinhard ^a   Risch, Angela ^b   Steinhagen Thiessen, Elisabeth ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MULTIINFARCT DEMENTIA; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; STROKE; TELOMERE;

EID: 0033747604     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780184     Document Type: Article

References (39)

1. Extension of life-span by introduction of telomerase into normal human cells
2. Telomere length and replicative aging in human vascular tissues
3. ACE, MTHFR, factor V Leiden, and ApoE polymorphisms in patients with vascular and Alzheimer's dementia
4. Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinsons disease
5. The rate of telomere sequence loss in human leukocytes varies with age
6. Age-dependent telomere shortening is slowed down by enrichment of intracellular vitamin C via suppression of oxidative stress
7. In an epidemiological sample the apolipoprotein E4 allele is associated to dementia and loss of memory function only in the very old
8. Status of risk factors for dementia associated with stroke
9. Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia
10. Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals
11. Role of glutathione-S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer
12. Classification, diagnosis and treatment of vascular dementia
13. Oxidative stress in brain ischemia
14. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease
15. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening
16. The relationship between apolipoprotein E, dementia, and vascular illness
17. Accumulation of short telomeres in human fibroblasts prior to replicative senescence
18. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease
19. Advanced telomere shortening in respiratory chain disorders
20. A theory of margitonomy
21. Preferential accumulation of single-stranded regions in telomeres of human fibroblasts
22. Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase
23. Clinical determinants of poststroke dementia
24. Telomerase: Dr. Jekyll or Mr Hyde?
25. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
26. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoetic stem cells and memory T cells in early childhood
27. Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments
28. Telomere length as a marker of oxidative stress in primary human fibroblast cultures
29. Accelerated telomere shortening in fibroblasts after extended periods of confluency
30. Genetic determination of telomere size in humans: A twin study of three age groups
31. Determination of glutathione-S-transferase mu and theta polymorphisms in neurological disease
32. Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia
33. Loss of telomeric DNA during aging of normal and trisomy 21 human leukocytes
34. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose)polymerase
35. The role of oxidative stress in telomere length regulation and replicative senescence
36. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: A model for senescence?
37. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts
38. Evidence for a new step in telomere maintenance